EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Efficacy of Hellebrigenin Against Nasopharyngeal Carcinoma Cells: The Molecular and Bioinformatic Analysis

Hsin-Yu Ho iD, Mu-Kuan Chen, Yun-Jung Tsai, Chia-Chieh Lin iD, Yu-Sheng Lo, Yi-Ching Chuang, Ming-Ju Hsieh iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Hsin-Yu Ho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oral Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Computational Biology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changhua Christian Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nasopharyngeal carcinoma (NPC) is a unique cancer type originating from the nasopharynx. To investigate novel strategies for improving prognosis and reducing the adverse effects of current treatments, this study examined the efficacy of hellebrigenin. Hellebrigenin demonstrated selective cytotoxicity against NPC‐BM and NPC‐039 cell lines without harming normal nasopharyngeal cells. Treatment with hellebrigenin resulted in G2/M cell cycle arrest in both NPC cell lines. The apoptotic phenomena induced by hellebrigenin included chromatin condensation, increased apoptotic cells and altered mitochondrial membrane potential. Proteomics analysis and the bioinformatic data identified coiled‐coil‐helix‐coiled‐coil‐helix domain containing 2 (CHCHD2) as a candidate oncogene in NPC. Moreover, the combination of CHCHD2 siRNA, CHCHD2 plasmid and hellebrigenin pointed out that CHCHD2 could be a critical mediator of hellebrigenin‐induced apoptosis. The combined treatment of hellebrigenin with mitogen‐activated protein kinase inhibitors revealed the involvement of the extracellular signal–regulated kinases and c‐Jun N‐terminal kinases pathways in hellebrigenin‐induced apoptosis in NPC cells. In vivo studies demonstrated that hellebrigenin suppressed the tumour volume without affecting body weight, accompanied by the downregulation of Ki67 and CHCHD2 expression. In conclusion, this study provides evidence that hellebrigenin induces NPC apoptosis through regulating CHCHD2 both in vitro and in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsComputational BiologyHumansCell Line, TumorApoptosisAnimalsMembrane Potential, MitochondrialXenograft Model Antitumor AssaysMice, NudeCell ProliferationMiceGene Expression Regulation, NeoplasticG2 Phase Cell Cycle Checkpoints

Stichwörter der Autor:innen

CHCHD2MAPKs pathwayapoptosishellebrigeninnasopharyngeal carcinoma

Autor:innen und Institutionen

  • Oral Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, Changhua, Taiwan.
  • Graduate Institute of Clinical Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
  • Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan.
  • Translational Pathology Core Laboratory, Changhua Christian Hospital, Changhua, Taiwan.
  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.

ORCID-Profile: Hsin-Yu Ho, Chia-Chieh Lin, Ming-Ju Hsieh

Förderung

  • Changhua Christian Hospital

Zitieren

APA

Ho, H. Y., Chen, M. K., Tsai, Y. J., Lin, C. C., Lo, Y. S., Chuang, Y. C., & Hsieh, M. J. (2025). The Efficacy of Hellebrigenin Against Nasopharyngeal Carcinoma Cells: The Molecular and Bioinformatic Analysis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70624

Vancouver

Ho HY, Chen MK, Tsai YJ, Lin CC, Lo YS, Chuang YC, et al. The Efficacy of Hellebrigenin Against Nasopharyngeal Carcinoma Cells: The Molecular and Bioinformatic Analysis. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70624

BibTeX
@article{Ho2025,
  author = {Ho, Hsin-Yu and Chen, Mu-Kuan and Tsai, Yun-Jung and Lin, Chia-Chieh and Lo, Yu-Sheng and Chuang, Yi-Ching and Hsieh, Ming-Ju},
  title = {The Efficacy of Hellebrigenin Against Nasopharyngeal Carcinoma Cells: The Molecular and Bioinformatic Analysis},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70624}
}
Kostenlos starten →